Smart Walk App for Physical Activity
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Smart Walk App treatment for increasing physical activity?
Is the Smart Walk App generally safe for humans?
How is the Smart Walk App treatment different from other treatments for increasing physical activity?
What is the purpose of this trial?
The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.
Eligibility Criteria
This trial is for African American women who are looking to increase their physical activity to reduce the risk of heart disease and type 2 diabetes. The details on specific eligibility criteria have not been provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Smart Walk intervention or a Fitbit-only comparison for an active 4-month intervention period
Follow-up
Participants are monitored for safety and effectiveness after treatment with minimal contact
Treatment Details
Interventions
- Smart Walk
Smart Walk is already approved in United States for the following indications:
- Increasing physical activity
- Reducing risk for heart disease and type 2 diabetes among African American women
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator